Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/13011
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorBarber Hernández, Domingo-
dc.creatorGómez Casado, Cristina-
dc.creatorVillaseñor Solis, Alma Cristina-
dc.date2021-
dc.date.accessioned2021-09-16T04:00:14Z-
dc.date.available2021-09-16T04:00:14Z-
dc.date.issued2021-09-16-
dc.identifier000000723596-
dc.identifier.urihttp://hdl.handle.net/10637/13011-
dc.descriptionEn colaboración con: Katja Baerenfaller, Alma Villaseñor, Cristina Gómez Casado, Domingo Barber-
dc.descriptionEn: Global atlas of asthama. Zurich: European Academy of Allergy and Clinical Immunology, 2021 . págs. 197-199-
dc.description.abstractOmics technologies are based on the acquisition and analysis of a large data volumes, using fast and automated high-performance methods. They have brought along a paradigm shift in the development of research strategies. Genomics, Epigenomics, Transcriptomics, Proteomics and Metabolomics are by now widely applied to identify biological variants, to characterize complex biochemical systems, to study pathophysiological processes and to define new biomarker strategies (Figure 1). Each omics discipline provides different information on the regulation of gene expression in health and diseases such as asthma.en-EN
dc.formatapplication/pdf-
dc.language.isoen-
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectCiencias ómicases-ES
dc.titleOmics.-
dc.typeCapítulo-
dc.centroUniversidad San Pablo-CEU-
Aparece en las colecciones: Facultad de Farmacia




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.